Diagnosis and Treatment of Hyperandrogenism
For diagnosing biochemical hyperandrogenism, free testosterone (FT) and total testosterone (TT) should be used as first-line laboratory tests, preferably measured using liquid chromatography with tandem mass spectrometry (LC-MS/MS) for highest accuracy. 1
Diagnostic Approach
Clinical Assessment
- Evaluate for common clinical manifestations of hyperandrogenism including hirsutism (using modified Ferriman-Gallwey scoring), acne, androgenic alopecia, and in severe cases, virilization 2, 3
- Assess for menstrual irregularities, as hyperandrogenism often presents with oligo/anovulation 4, 5
- Record body mass index and blood pressure, as metabolic complications are common with hyperandrogenic conditions 4
Laboratory Testing
First-line testing should include:
Second-line testing (if TT or FT not elevated):
For severe or rapidly progressive hyperandrogenism with virilization:
Differential Diagnosis
- Polycystic ovary syndrome (PCOS) - most common cause of hyperandrogenism 4, 6
- Non-classic congenital adrenal hyperplasia (NCCAH) 6
- Cushing's disease 6
- Androgen-secreting tumors (ovarian or adrenal) 3, 6
- Idiopathic hyperandrogenism 5
- Physiologic hyperandrogenism of puberty 5
Treatment Options
Pharmacological Approaches
First-line treatment: Combined oral contraceptives (COCs)
Antiandrogen therapy:
Cosmetic Management for Hirsutism
- Short-term options: shaving, chemical depilation, plucking, threading, waxing, and bleaching 2
- Long-term options: electrolysis, laser therapy, and intense pulse light therapy 2
- Topical eflornithine hydrochloride can be used as adjunctive therapy 2
Metabolic Management
- Screen for and manage metabolic complications, particularly insulin resistance 4
- Consider lifestyle modifications including diet and exercise for overweight/obese patients 4
Treatment Response Timeline
- Acne typically responds relatively quickly to therapy 2
- Hirsutism improvement may be observed as early as 3 months, but typically requires 6-8 months of consistent therapy 2
- Female pattern hair loss (FPHL) is slowest to respond, potentially requiring 12-18 months of therapy, and may not improve in all cases 2
Important Clinical Considerations
- Virilization (clitoromegaly, deepening voice, increased muscle mass) is uncommon in typical hyperandrogenism and warrants investigation for androgen-secreting tumors 3, 6
- The psychological impact of hyperandrogenism symptoms should be addressed as part of comprehensive care 4
- Treatment should not be withheld during ongoing evaluation for underlying causes 5
- Patient expectations regarding treatment timeline and efficacy should be discussed before initiating therapy 5